CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Grissinger Michael Director | Grant or award | +3,135 | 6,024 | ||
| 2026-06-16 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2025-06-05 | Grissinger Michael Director | Grant or award | +1,045 | 2,889 | ||
| 2025-06-05 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | Grissinger Michael Director | Grant or award | +1,045 | 1,844 | ||
| 2024-06-20 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2023-08-23 | Grissinger Michael Director | Grant or award | +500 | 799 | ||
| 2023-08-23 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2022-07-28 | Grissinger Michael Director | Grant or award | +5,995 | 5,995 | ||
| 2022-07-28 | Grissinger Michael Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 |
Page 1 of 1 · 10 trades